412074007: Abacavir sulfate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Transferase inhibitor\Reverse transcriptase inhibitor\Abacavir sulfate (substance)
\Substance categorized by disposition\Substance with antiviral mechanism of action (substance)\Substance with antiretroviral mechanism of action (substance)\Reverse transcriptase inhibitor\Abacavir sulfate (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Substance with antiviral mechanism of action (substance)\Substance with antiretroviral mechanism of action (substance)\Reverse transcriptase inhibitor\Abacavir sulfate (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Nucleoside\Nucleoside analogue\Abacavir sulfate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2004. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2467526019 Abacavir sulfate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

2469308014 Abacavir sulphate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

2469782010 Abacavir sulfate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3176901000005116 abacavirsulfat da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Abacavir sulfate (substance)	Is a	Abacavir (substance)	false	Inferred relationship	Some
Abacavir sulfate (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Protease inhibitor (disposition)	false	Inferred relationship	Some
Abacavir sulfate (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Abacavir (substance)	true	Inferred relationship	Some
Abacavir sulfate (substance)	Is a	Drug allergen	false	Inferred relationship	Some
Abacavir sulfate (substance)	Is a	Protease inhibitor	false	Inferred relationship	Some
Abacavir sulfate (substance)	Is a	kemisk stof specificeret iht. funktion	false	Inferred relationship	Some
Abacavir sulfate (substance)	Is a	Purine	false	Inferred relationship	Some
Abacavir sulfate (substance)	Is a	Substance with effector mechanism of action (substance)	false	Inferred relationship	Some
Abacavir sulfate (substance)	Is a	Reverse transcriptase inhibitor	true	Inferred relationship	Some
Abacavir sulfate (substance)	Is a	Purine analog (substance)	false	Inferred relationship	Some
Abacavir sulfate (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Reverse transcriptase inhibitor (disposition)	true	Inferred relationship	Some
Abacavir sulfate (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	A substance that competes with, replaces or inhibits a specific metabolite of a cell and thereby interferes with the cell's normal metabolic functioning.	false	Inferred relationship	Some
Abacavir sulfate (substance)	Is a	Nucleoside analogue	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
abacavirsulfat 300 mg + lamivudin 150 mg + zidovudin 300 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Abacavir sulfate (substance)	Inferred relationship	Some
Abacavir sulfate + lamivudine + zidovudine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Abacavir sulfate (substance)	Inferred relationship	Some
abacavirsulfat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Abacavir sulfate (substance)	Inferred relationship	Some
Abacavir (as abacavir sulfate) 20 mg/mL oral solution	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Abacavir sulfate (substance)	Inferred relationship	Some	1
Abacavir (as abacavir sulfate) 300 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Abacavir sulfate (substance)	Inferred relationship	Some	1
Abacavir (as abacavir sulfate) 600 mg and lamivudine 300 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Abacavir sulfate (substance)	Inferred relationship	Some	2
Abacavir (as abacavir sulfate) 60 mg dispersible oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Abacavir sulfate (substance)	Inferred relationship	Some	1
Product containing precisely abacavir (as abacavir sulfate) 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Abacavir sulfate (substance)	Inferred relationship	Some	2
Product containing precisely abacavir (as abacavir sulfate) 120 milligram and lamivudine 60 milligram/1 each tablet for conventional release oral suspension (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Abacavir sulfate (substance)	Inferred relationship	Some	2
Product containing precisely abacavir (as abacavir sulfate) 600 milligram and dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Abacavir sulfate (substance)	Inferred relationship	Some	2

This concept is not in any reference sets